Actionable news
All posts from Actionable news
Actionable news in IBB: iShares NASDAQ Biotechnology Index Fund,

‘You’ve got to be a buyer’ of biotech: Technician

Biotech's rally has excited investors and led one technician to reaffirm the sector as one that's worth to buy.

Jonathan Krinsky, chief market technician at MKM Partners, took a look at the biotech sector rally and sees a continue to the industry's rise.

"You have to remember that biotech's one of the top five performing industry groups since the Brexit low," Krinsky said Monday on CNBC's "Power Lunch." "But despite that, it's still one of the worst five industry groups over the last year. So we think the catch-up trade that's been happening over the last two months is probably set to continue."

On a chart of the Nasdaq biotech ETF IBB, Krinsky points out that the sector has recovered since a...